In summary, the pathogenesis of AD is marked by a convergence of skin barrier defects, dysregulated Th2 immunity, and microbial dysbiosis, with the IL-31/IL-33 axis emerging as a central player in linking immune activation and neurogenic inflammation. The gene discussed is IL33; the disease is Alzheimer disease.